Validation and Comparison of PROMISE and CONFIRM Model to Predict High-Risk Coronary Artery Disease in Symptomatic and Diabetes Mellitus Patients

CONCLUSIONS: Compared to CHM, PHM was associated with a more accurate prediction for HRCAD and might optimize downstream management strategy in symptomatic patients with DM.CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov (NCT04691037).PMID:35345247 | DOI:10.31083/j.rcm2303080

Source: Reviews in Cardiovascular Medicine - March 29, 2022 Category: Cardiology Authors: Hantao Jiang Jinping Feng Chao Feng Pei Ren Kai Ren Ying Jin Jia Zhou Source Type: research